SAMYANG HOLDINGS CORP BY ORDER OF SAMYANG BIOPHARMACEUTICALS CORPORATION

Company Type: Manufacturer

Company Introduction:

Samyang Biopharmaceuticals Corporation is a pharmaceutical manufacturing company and a key subsidiary operating under Samyang Holdings Corporation, a well-established South Korean conglomerate. Samyang Holdings, founded in 1924, is a diversified enterprise with extensive business interests including chemicals, food, industrial materials, and the biopharmaceutical sector.

Samyang Biopharmaceuticals Corporation is primarily engaged in the research, development, manufacturing, and commercialization of innovative biopharmaceutical products, medical devices, and specialized bio-materials. The company's core areas of expertise include oncology (anti-cancer drugs), surgical sutures, and advanced drug delivery systems. They operate dedicated manufacturing facilities to produce their high-quality pharmaceutical and medical products, aiming to contribute significantly to global healthcare through scientific advancement and patient-focused solutions.

Samyang Holdings Corp, by order of Samyang Biopharmaceuticals Corporation, produces and sells the following products:

* **Biosimilars:** Remsima SC (infliximab biosimilar)

* **New Drugs:**

* Next generation chemotherapy

* Fibrosis treatment

* **CDMO (Contract Development and Manufacturing Organization) services:** Biologics CDMO

* **Medical Devices:**

* Laparoscopic surgical tools

* Hemostatic materials